Tech talent comes to healthcare

In San Francisco a few weeks ago, I caught up with Nworah Ayogu, partner at Thrive Capital. Thrive had recently announced that it raised a

Plus, news about Eledon, Sobi, Ovid and CytomX:

🗓️ Ionis updates prion disease study timelines: The California oligonucleotide powerhouse has pushed back the primary completion of its Phase 1/2a trial to February 2027, from an …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844